磷酸化
蛋白激酶A
激酶
磷酸肽
地图2K7
丝裂原活化蛋白激酶激酶
生物化学
细胞周期蛋白依赖激酶2
重组DNA
化学
突变
分子生物学
生物
突变
基因
作者
Gregory A. Jicha,Audrey O' Donnell,Charles Weaver,Ruth Hogue Angeletti,Peter J. Davies
标识
DOI:10.1046/j.1471-4159.1999.0720214.x
摘要
Abstract : Immunoaffinity‐purified paired helical filaments (PHFs) from Alzheimer's disease (AD) brain homogenates contain an associated protein kinase activity that is able to induce the phosphorylation of PHF proteins on addition of exogenous MgCl 2 and ATP. PHF kinase activity is shown to be present in immunoaffinity‐purified PHFs from both sporadic and familial AD, Down's syndrome, and Pick's disease but not from normal brain homogenates. Although initial studies failed to show that the kinase was able to induce the phosphorylation of tau, additional studies presented in this article show that only cyclic AMP‐dependent protein kinase‐pretreated recombinant tau is a substrate for the PHF kinase activity. Deletional mutagenesis, phosphopeptide mapping, and site‐directed mutagenesis have identified the PHF kinase phosphorylation sites as amino acids Thr 361 and Ser 412 in htau40. In addition, the cyclic AMP‐dependent protein kinase phosphorylation sites that direct the PHF kinase have been mapped to amino acids Ser 356 and Ser 409 in htau40. Additional data demonstrate that these hierarchical phosphorylations in the extreme C terminus of tau allow for the incorporation of recombinant tau into exogenously added AD‐derived PHFs, providing evidence that certain unique phosphorylations of tau may play a role in the pathogenesis of neurofibrillary pathology in AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI